RecruitingPhase 3NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Sponsor: Merck Sharp & Dohme LLCChattanooga, TN · Knoxville, TN · Memphis, TN · +51 more sites
RecruitingPhase not listedNCT07428447Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's DiseaseSponsor: CND Life SciencesMemphis, TN · Nashville, TN · +6 more sites
RecruitingPhase 3NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseSponsor: Hoffmann-La RocheMemphis, TN · Nashville, TN · +51 more sites
RecruitingPhase 2 / Phase 3NCT07284784A Study of Buntanetap in Participants With PDSponsor: Annovis Bio Inc.Cordova, TN · Memphis, TN · +25 more sites
RecruitingPhase 2NCT07804615A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic TherapySponsor: Vima TherapeuticsMemphis, TN · +28 more sites